v3 Template
P

PlantForm Corporation

Biopharmaceutical ~320 employees
Founded
--
Employees (Est.)
~320
16 leaders known
Total Funding
$50.0M
Funding Rounds
2
Last Funding
2024-06-12

About PlantForm Corporation

PlantForm Corporation is a biopharmaceutical company dedicated to the rapid development and production of specialty antibody and protein drugs using their proprietary vivoXPRESS® platform. This plant-based system aims to make the production of approved biologic drugs easier, faster, and less expensive for novel indications and new markets.

Products & Services

Biosimilar Drugs:Biosimilar versions of Keytruda®, Lucentis®, and other niche indication drugs.
Medical Countermeasures:Countermeasures to terrorism threats such as ricin and sarin.
Animal Health Programs:Programs to prevent Porcine Epidemic Diarrhea Virus (PEDv) and E.coli infections.
CDMO Services:Contract Development and Manufacturing Organization services.

Specialties

Rapid development of antibody and protein drugs Plant-based vivoXPRESS® platform Biopharming Low-cost biologic drug production Versatile manufacturing Unlimited scale-up capability

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Equity
T: -
FT: Equity
A: 25000000
MR: -
FA: $25 million
FAN: 25000000
D: 2024-06-12
FD: 2024-06-12
-
2 RT: Debt and Equity
T: -
FT: Debt and Equity
A: 25000000
MR: -
FA: $25 million
FAN: 25000000
D: 2023-08-31
FD: 2023-08-31
-
Equity Latest
2024-06-12
$25.0M
Debt and Equity 2023-08-31
$25.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

D

Don Stewart

President and Chief Executive Officer

D

David Cayea

Chief Operating Officer

R

Ron Hosking

CPA, CA, Chief Financial Officer, PlantForm Founder, Interim Chair of PlantForm's Board of Directors

D

Doug Cossar

Vice-President, Research

M

Mark Goldberg

Co-founder & former CEO, GlobalTox

D

David Fraser

President of AEGIS Six Corporation

View 13 more team members with Pro

Unlock Full Team Directory

Recent News

PlantForm Corporation Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biopharmaceutical
Company Size
~320 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro